Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting

To examine pharmacologic and clinical characteristics of neurokinin 1 (NK(1))-receptor antagonists (RAs) for preventing chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy, a literature search was performed for clinical studies in patients at risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Navari, Rudolph M, Schwartzberg, Lee S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178341/
https://www.ncbi.nlm.nih.gov/pubmed/30323622
http://dx.doi.org/10.2147/OTT.S158570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178341/
https://www.ncbi.nlm.nih.gov/pubmed/30323622
http://dx.doi.org/10.2147/OTT.S158570

Ejemplares similares